Latka logo
PathoQuest logo

PathoQuest

Paris, Ile-de-france, France

2024 Revenue

$5.9M

Funding

$24.1M

YOY

46.1%

Team

56

Founded

2010

How PathoQuest CEO Jean François Brepson grew to $5.9M revenue with a 56 person team in 2024.

Developer of a molecular diagnostics technology designed to improve pathogen detection in biological samples. The company's technology combines sample preparation technology and cloud-based bioinformatics which is applicable to several types of samples with a proprietary pathogen genome sequence database and automated analysis pipeline, enabling doctors to improve the breadth of pathogen detection.

Last updated

PathoQuest Revenue

In 2024, PathoQuest's revenue reached $5.9M. The company previously reported $4M in 2023. Since its launch in 2010, PathoQuest has shown consistent revenue growth.

PathoQuest Revenue GrowthReported revenue / ARR over time$0$1M$3M$4M$5M$6M20102012201420162018202020222024$0$3M$4M$6MSource: GetLatka.com
YearMilestoneQuote
2024PathoQuest Hit $5.9m revenue in October 2024
2023PathoQuest Hit $4m revenue in October 2023
2021PathoQuest Hit $3.1m revenue in April 2021
2010Launched with $0 revenue

PathoQuest Valuation, Funding Rounds

PathoQuest has not publicly disclosed its valuation. The company has raised $24.1M in total funding to date.

PathoQuest has raised $24.1M in total funding across 5 rounds, with its most recent round in 2019.

PathoQuest Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$0$0.2$6M$0.4$12M$0.6$18M$0.8$24M$1$30M201020122014201620182019Source: GetLatka.com
YearRoundAmountValuation% SoldQuote
2019Funding round$9.8M--
2018Funding round$4.9M--
2015Funding round$2.4M--
2013Funding round$4.6M--
2011Funding round$2.4M--

Founder / CEO

Jean François Brepson

Jean-François Brepson has over 20 years leadership experience in the Pharmaceutical Industry. Prior to joining PathoQuest, Mr. Brepson was a Senior Vice-President at IPSEN where he was responsible for leading the global GI-Oncology & Endocrinology Franchise. He made a decisive contribution to the creation of leading portfolio in Neuro-EndocrineTumors in close collaboration with R&D and Business Development teams. He led the pre-launch of IPSEN first product in GI-Oncology on a worldwide basis. Prior to this, Mr. Brepson held several commercial operations positions at IPSEN including area Manager, BU Head, and General Manager in the EMEA region. Mr. Brepson has an Engineering Degree in Data Management System and a Master Degree in Foreign Trade. He has also earned "The Leadership & Innovation Certificate" for HEC in Paris and "The Blue Ocean Strategy Certificate" from INSEAD in Fontainebleau.

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for PathoQuest yet.

PathoQuest Employees & Team Size

PathoQuest employs approximately 56 people as of 2026, up from 47 in 2023, including 1 sales reps that carry a quota.

PathoQuest Team GrowthReported headcount over time0132538506320102012201420162018202020222024005656Source: GetLatka.com
YearMilestone
2024Reached 56 employees (December 2024)
2024Reached 47 employees (October 2024)
2023Reached 47 employees (October 2023)
2022Reached 51 employees (October 2022)
2021Reached 44 employees (December 2021)
2021Reached 36 employees (April 2021)

Frequently Asked Questions about PathoQuest

What is PathoQuest's revenue?

PathoQuest generates $5.9M in revenue.

Who founded PathoQuest?

PathoQuest was founded by Jean François Brepson.

Who is the CEO of PathoQuest?

The CEO of PathoQuest is Jean François Brepson.

How much funding does PathoQuest have?

PathoQuest raised $24.1M.

How many employees does PathoQuest have?

PathoQuest has 56 employees.

Where is PathoQuest headquarters?

PathoQuest is headquartered in Paris, Ile-de-france, France.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile

People Also Viewed

Chattermill Analytics logo

Chattermill Analytics

Copilot transforms the way you interact with your customer data. With the power of generative AI, you can get answers to all of your CX, product, and marketing questions, improving team alignment, efficiency, and productivity. Have questions? Just ask!

Sentisis logo

Sentisis

Sentisis is the Customer Experience platform for the Spanish language

SPOT logo

SPOT

Provider of a cloud based measurement software designed to make cloud computing more accessible and practical through simplicity and technical resources driven by the community. The company's cloud based measurement software uses artificial intelligence and machine learning to capture and analyze the data of the real world through video to predict and establish more precise marketing strategies, enabling businesses to optimize processes and gain competitive advantage.

Tactile Mobility (formerly MobiWize) logo

Tactile Mobility (formerly MobiWize)

Provider of a device sensing platform intended to transform the mobility industry. The company's platform comprises of two advanced software modules that can be provided as standalone or combined together to gather signal processing data, enabling clients to avail safer, efficient and enjoyable driving experience.

Tera logo

Tera

Tera is a AI powered smarter finance platform offering unified experience for businesses

Tauri logo

Tauri

Developer of a cloud based cyber security platform designed to provide effective and secure services to business across all places. The company's cyber security platform stores and safeguards confidential and classified information from threats and enables only the sender and recipient have access to encryption keys that are used to open communications and other files through web browsers, mobile phones, Windows and Mac, enabling organizations to handle communication, scheduling and file management in a secured way.

PathoQuest Revenue 2024: $5.9M ARR, $24.1M Raised